Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

This study is a long-term follow-up for patients who previously participated in a clinical trial of fenofibrate (a medication typically used for cholesterol) as a treatment for primary biliary cholangitis (PBC) — a chronic liver disease where the immune system attacks the bile ducts. **You may be eligible if...** - You previously participated in the fenofibrate PBC clinical trial (NCT02823353) - You are using appropriate contraception if you are of reproductive potential **You may NOT be eligible if...** - You had to stop taking fenofibrate in the previous trial due to a treatment-related side effect - You have another medical condition that your doctor believes would prevent you from safely completing this study Talk to your doctor to see if this trial is right for you.